Nuclear hormone receptors and intestinal inflammation.
Wu
Gary D
GD
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D005759:Gastroenteritis / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D005765:Gastrointestinal Agents / Q000494:pharmacology / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000187:drug effects; D008024:Ligands; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism; D011110:Polymorphism, Genetic; D000077297:Pregnane X Receptor; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D018168:Receptors, Retinoic Acid / Q000378:metabolism; D011987:Receptors, Steroid / Q000378:metabolism; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use; D014157:Transcription Factors / Q000378:metabolism; D000099150:Receptor, Farnesoid X-Activated
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D004268:DNA-Binding Proteins; D005765:Gastrointestinal Agents; D008024:Ligands; D047492:Peroxisome Proliferator-Activated Receptors; D000077297:Pregnane X Receptor; D018160:Receptors, Cytoplasmic and Nuclear; D018168:Receptors, Retinoic Acid; D011987:Receptors, Steroid; D045162:Thiazolidinediones; D014157:Transcription Factors; D000099150:Receptor, Farnesoid X-Activated